Your browser doesn't support javascript.
loading
A Protease Activatable Interleukin-2 Fusion Protein Engenders Antitumor Immune Responses by Interferon Gamma-Dependent and Interferon Gamma-Independent Mechanisms.
Norville, Karli; Skrombolas, Denise; Ferry, Shannon L; Kearns, Nolan; Frelinger, John G.
Affiliation
  • Norville K; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
  • Skrombolas D; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
  • Ferry SL; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
  • Kearns N; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
  • Frelinger JG; Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, USA.
J Interferon Cytokine Res ; 42(7): 316-328, 2022 07.
Article in En | MEDLINE | ID: mdl-35834651
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Interferon-gamma / Interleukin-2 / Cell Line, Tumor / Tumor Microenvironment / Immunity Limits: Animals Language: En Journal: J Interferon Cytokine Res Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Interferon-gamma / Interleukin-2 / Cell Line, Tumor / Tumor Microenvironment / Immunity Limits: Animals Language: En Journal: J Interferon Cytokine Res Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States